Re: ZHCLF trades on the OTC
in response to
by
posted on
Jan 19, 2021 07:16PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
ryau1135,,,,,are you recieving any literature or voting documents for Zenith since buying OTC, if you do own the shares one would think these documents would be mailed to you?